I suspect the company has troubles with their new client onboarding. They have always had a lag from ARR to revenue, at end of last financial year it was about 1.4m ARR that wasn't onboarded yet. I suspect there's a leak between sales and onboarding.
Either sales are getting signatures on low quality deals (my guess), or new client onboarding is ineffective or under resourced.
This quarter was a very bad quarter even with what was supposed to be strong tailwinds. I wonder if they've written off a bunch of ARR that was never onboarded.
Either way, massive management fail to miss so badly. At 5.2m ARR, they're half a year behind projections from a year ago. For ARR to grow 1% in a quarter is crazy for a supposed growth company, starting off a tiny base, where the market itself is growing.
I still like the stock, but IMO there's something seriously wrong in management. I hope I'm wrong.
- Forums
- ASX - By Stock
- VFX
- Ann: Quarterly Update
Ann: Quarterly Update, page-41
Featured News
Add VFX (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $13.13M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $19.05K | 3.825M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 18377843 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 2034432 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 18377843 | 0.004 |
10 | 28623585 | 0.003 |
2 | 950000 | 0.002 |
2 | 1200000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 2034432 | 2 |
0.006 | 1027075 | 3 |
0.007 | 5000000 | 1 |
0.008 | 250000 | 1 |
0.009 | 250000 | 1 |
Last trade - 12.36pm 15/11/2024 (20 minute delay) ? |
Featured News
VFX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online